Clinical Trial Update: Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 preventive HPV vaccine trial in kidney transplant recipients has posted results (2025-12-30) and is currently listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Human Papillomavirus-related Carcinoma

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papillomavirus Infection, Human Papillomavirus-Related Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-30